Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Heather Boerner is an award-winning journalist who specializes in storytelling on healthcare issues. She's most interested in how people choose between equally important needs.
The health and prevention benefits of an undetectable viral load may be uniquely important in the American health care system.
Compared to other common HIV treatments, dolutegravir-based regimens maintained viral suppression even without perfect adherence.
Some types of lymphoma are considered AIDS-defining illnesses, but that doesn’t mean they’re caused by HIV itself.
Descovy may be a better option than Truvada for those at risk for kidney problems.
Here are considerations for long-term survivors thinking about switching HIV treatments.
Under 30? Here’s what to consider if you’re thinking about switching HIV treatments.
Switching to a long-acting injectable was right on time for these three people living with HIV.
Despite effective treatment, Black women continue to bear the brunt of HIV mortality.
Gay and bi men who used drugs during sex were also more likely to miss doses of their HIV meds.
El dolor crónico es una realidad para demasiada gente que vive con el VIH.
People in JumpstART achieved viral suppression three times faster than those in the control group.
A cross-sectional study asked 50 people which of six different models of care would make HIV treatment doable for them.
The first data from the much anticipated REPRIEVE trial on statin medications for people with HIV are out.
A study suggests that pre-exposure prophylaxis (PrEP) pills work at full potency in women of trans experience who use feminizing hormones.
Unstable housing is also associated with a higher HIV viral load.
Markers of immune activation rose, but only temporarily, around the transition to menopause.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.